Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina
Enables content for newly launched Illumina MiSeq™ i100 and expands Illumina oncology panel portfolio to include targeted liquid biopsy panels Natick, MA – October 16, 2024 – Pillar Biosciences, Inc., the leader in Decision Medicine™, has today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar’s oncoReveal™ NGS panels will now be […]
Pillar Biosciences Announces Expansion of NGS Commercial Partnership with Illumina Read More »